Aerobic Fitness in Overweight and Obese Individuals

Vedic Lifesciences logo

Vedic Lifesciences

Status

Terminated

Conditions

Healthy

Treatments

Dietary Supplement: Oxyjun
Dietary Supplement: Pacebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT03854786
EB/181201/OXYJUN/EVRG

Details and patient eligibility

About

Oxyjun is known for improving cardiovascular endurance. Overweight and obese individuals are at increased risk of cardiovascular complications. To lower the risk, these individuals need to remain physically active with acceptable aerobic fitness. Hence, the objective of the study is to investigate the effect of Oxyjun on aerobic fitness in physically active overweight and obese individuals. All subjects in the study will be tested for maximum aerobic capacity , body composition, and serum biomarker for fitness.

Enrollment

11 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Body Mass Index ≥ 25 - ≤ 34.9 kg/m2. Waist Circumference ≥ 80 cms. Non-smoker. BP ≤ 140/90 mm Hg FBS ≤ 125 mg/dl Hb ≥ 11 g/ dl Can abstain from strenuous exercise and alcohol for at least 48 hours. Can abstain from caffeine for at least 24 hours.

Exclusion criteria

Participants with history of regular (≥2 times a week) structured exercise (gym, walking, yoga, etc). Inter-arm blood pressure is ≥10 mm Hg. Known cases of type II Diabetes Mellitus. Known cases of hypertension with or without anti-hypertensive medication. Visual or balance problems, or who cannot walk on a treadmill without using the handrails.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

11 participants in 2 patient groups, including a placebo group

Oxyjun
Active Comparator group
Description:
Oxyjun- 400 mg OD after breakfast
Treatment:
Dietary Supplement: Oxyjun
Methyl Crystalline Cellulose
Placebo Comparator group
Description:
Methyl Crystalline Cellulose- 400 mg OD after breakfast
Treatment:
Dietary Supplement: Pacebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems